The Numbers That Make You Stop
I’m a procurement manager at a 200-person specialty coatings firm. I’ve managed our raw materials budget—about $4.2 million annually—for the past 7 years. When I reviewed Eastman Chemical’s 2024 Form 10-K a few weeks ago, one number stopped me cold. Not the net sales of approximately $9.1 billion (down about 2% from 2023, according to the filing). No, it was something tucked deeper in the commentary: the cost of goods sold as a percentage of revenue shifted by a full percentage point in the wrong direction.
Most analysts, I suspect, will glance at the headline—'net sales dip'—and move on. But for anyone who’s actually managed a supply chain, the real story isn't the revenue number. It’s the cost structure underneath. Because that’s where the hidden decisions live.
“In my experience tracking 40+ quarterly earnings reports over 6 years, the first question everyone asks is ‘what’s the revenue growth rate?’ The question they should ask is ‘what’s the unit cost trend in their highest-volume product lines?’”
The Surface Problem: Net Sales Are Down. But That’s the Cover, Not the Book.
According to the 2024 10-K (eastman.com), Eastman Chemical reported a net sales decline of roughly 2% year-over-year. That’s the surface problem. The kind of problem that makes headlines and drives stock twitch. But if you’re a buyer of specialty chemicals for construction adhesives, sealants, or plastic building materials—which I am—that number alone doesn’t tell you anything useful.
Here’s what the surface problem looks like in practice. We buy Eastman’s tackifiers and adhesion promoters. In Q3 2024, our cost per pound for one key raw material went up 4% year-on-year. At the same time, the volume we needed actually decreased because one of our projects was delayed. So our spend with Eastman dropped. Was that a revenue problem for them? Yes. Was it a demand problem? No. It was a project timing issue on our side. A logjam in the construction cycle, not a chemical market collapse.
That’s the trap. The headline—'net sales down'—suggests weakening demand. But the reality, from where I sit, is more nuanced. The sales decline is a proxy for something else.
The Deeper Root: The Hidden Cost of ‘Good Enough’ Volumes
Here’s the part I don’t see in the press coverage. When you read the 10-K carefully—and I printed the whole thing; it’s 140+ pages—the conversation is dominated by volumes and prices. But the real conversation, in my experience, is about product mix and fixed cost absorption.
Eastman’s advanced materials segment—the stuff we use—probably runs at a different utilization rate than their additives and functional products segment. If you have three plants running at 70%, 85%, and 90% capacity, a 2% drop in aggregate revenue doesn’t hit equally. The plant at 70%—the one making the specialized building products we use—feels that 2% drop like a punch. Fixed costs (depreciation, base labor, maintenance) don’t go away. They get spread over fewer pounds. Which means the unit cost goes up. For them. For us.
Looking back, I should have flagged this sooner. At the time, in early 2024, we were all worried about demand. But the real signal was in the cost structure. We talked to Eastman’s technical team (not sales) at a conference in Nashville. The hint was there: they mentioned ‘optimizing plant scheduling.’ In procurement language, that usually means ‘we’re running below capacity and trying to avoid a cost spike.’ We didn’t decode it.
The Cost of Not Seeing the Real Problem
So what does it actually cost to miss this analysis? Let me give you a specific example from our own experience—and it maps directly to Eastman’s situation.
In Q2 2024, we requested a quote for a new formulation of a construction sealant. The base polymer was an Eastman product. The price quoted was 8% higher than our internal benchmark. At first, I assumed it was ‘price increase season.’ But when I dug deeper—tracking the cost index for that specific product family over 18 months—I realized the increase wasn’t about markup. It was about production efficiency. Eastman had shifted production of that intermediate from a high-volume, low-unit-cost plant to a smaller, more flexible line. Unit cost there was naturally higher. The 8% wasn’t greed. It was math.
The consequence: we held the line at 8% higher cost for three months while we tried to reformulate with an alternative supplier. That alternative failed validation at the sealant’s end-use test. We lost $4,200 in rework costs and delayed a client shipment by 10 days. If I had understood the real cost driver—Eastman’s plant utilization, not their list price—I would have accepted the quote immediately and saved us the rework. The ‘cheap’ option cost us more.
“In Q2 2024, the worst case was a complete batch failure—$15,000 in wasted material. The best case was saving 10% on the raw material cost. The expected value said gamble, but the downside felt catastrophic for a three-month supply. We gambled. We lost.”
That’s the cost of focusing on the surface problem. The 2% net sales drop isn’t the real issue. The real issue is that buyers like me—and investors, too—are reading the wrong numbers.
The Real Problem: Hidden Supply Chain Rigidity
Here’s what I think the true problem is, from the perspective of someone who has negotiated 50+ chemical supply contracts over the past decade. It’s not demand. It’s that Eastman’s cost structure has become less flexible at the very moment when end-market demand is becoming more lumpy.
Consider this. Eastman reported 2024 adjusted EBITDA margins of approximately 19.5% (according to their earnings supplement). That’s healthy. But the trajectory matters: margins compressed slightly from 2023 levels. When I see margin compression in a company with diverse product lines, I don’t worry about revenue. I worry about the weighted average cost of the mix. If the high-margin specialty products (like those we use for architectural coatings) hold steady but the higher-volume, lower-margin commodity lines take a volume hit, the margin drops disproportionately. This isn’t a demand crisis. It’s a portfolio math problem.
Most buyers focus on per-unit pricing for their specific product and completely miss this portfolio effect—which can add 30-50% to total cost over a contract cycle. The question everyone asks is ‘what’s your volume discount?’ The question they should ask is ‘what’s your plant utilization rate for this product line and how does it affect my unit economics over the next 12 months?’
I’m not saying the Board (which the 10-K lists as a highly experienced group of 11 directors, including CEOs with deep GE and DuPont backgrounds) isn’t watching this. They are. But from a procurement standpoint, I see a gap between their strategic view and the tactical cost reality hitting buyers.
What This Actually Means
So where does this leave us? I think Eastman Chemical remains a solid supplier. Their 2024 10-K shows a company managing a difficult period with discipline. But the takeaway for anyone sourcing from them—or any chemical supplier—isn’t about the net sales figure. It’s about digging into the cost drivers.
For our procurement team, the calculation now looks like this:
- The old view: ‘Eastman’s sales are down; they’ll be more flexible on price.’ (Wrong assumption.)
- The better view: ‘Eastman’s unit costs are rising due to mix shifts; locking in a 12-month contract now, before price adjustments fully roll through, might be the right move.’
If I could redo our Q2 2024 decision, I’d invest in a more structured conversation with their supply chain team—asking directly about capacity utilization and product-line cost trends. Given what I knew then (which was their published price list and our internal benchmarks), my choice was reasonable. But reasonable isn’t optimal.
Prices noted in this article are based on our actual quote data from Q2 2024. Verify current pricing with your Eastman representative before making decisions. The 10-K data references the 2024 Form 10-K filed with the SEC; available at eastman.com/investors.
